초록
연구배경
방법
Abstract
Background
Methods
Results
Conclusions
REFERENCES
Table 1.
Total (n=25,925) | Men (n=11,289) | Women (n=14,636) | Pb | |
---|---|---|---|---|
Age, y | ||||
20-29 | 24.2 | 23.6 | 24.8 | <0.001 |
30-49 | 52.6 | 49.7 | 55.9 | |
50-64 | 17.1 | 19.5 | 14.4 | |
65-74 | 4.2 | 5.0 | 3.3 | |
≥75 | 1.9 | 2.1 | 1.6 | |
Education | ||||
Elementary or less | 8.8 | 8.4 | 9.1 | 0.179 |
Junior high school | 7.7 | 7.9 | 7.4 | |
High school | 42.7 | 42.7 | 42.7 | |
College or more | 40.9 | 41.0 | 40.8 | |
Household income | ||||
Q1 (lowest) | 10.6 | 10.9 | 10.2 | 0.060 |
Q2 | 25.4 | 25.5 | 25.2 | |
Q3 | 31.8 | 32.1 | 31.5 | |
Q4 (highest) | 32.3 | 31.5 | 33.1 | |
Residence | ||||
Urban | 83.5 | 81.8 | 85.3 | <0.001 |
Rural | 16.5 | 18.2 | 14.7 | |
Currently smoking | ||||
Yes | 26.6 | 44.6 | 6.3 | <0.001 |
No | 73.4 | 55.4 | 93.7 | |
Currently consuming alcohol | ||||
Yes | 62.8 | 75.4 | 48.8 | <0.001 |
No | 37.2 | 24.6 | 51.2 | |
Physical activity | ||||
Yes | 42.9 | 44.5 | 40.9 | <0.001 |
No | 57.1 | 55.5 | 59.1 | |
Cardiovascular risk factors | ||||
BMI, kg/m2 | 23.3±0.0 | 23.9±0.0 | 22.6±0.0 | <0.001 |
Waist circumference, cm | 79.8±0.1 | 83.4±0.1 | 75.8±0.1 | <0.001 |
Total cholesterol, mg/dL | 184.7±0.3 | 186.8±0.4 | 182.5±0.4 | <0.001 |
Triglycerides, mg/dL | 116.1±0.6 | 134.3±0.9 | 95.7±0.6 | <0.001 |
HDL cholesterol, mg/dL | 50.5±0.1 | 47.5±0.1 | 53.8±0.1 | <0.001 |
LDL cholesterol, mg/dL | 111.0±0.3 | 112.4±0.4 | 109.5±0.3 | <0.001 |
Systolic blood pressure, mmHg | 113.5±0.1 | 117.5±0.2 | 109.1±0.2 | <0.001 |
Diastolic blood pressure, mmHg | 75.2±0.1 | 78.3±0.1 | 71.8±0.1 | <0.001 |
Fasting blood glucose, mg/dL | 93.2±0.1 | 94.7±0.2 | 91.5±0.2 | <0.001 |
Prevalence of cardiovascular risk factors | ||||
Obesity | 27.6 | 33.6 | 20.8 | <0.001 |
Metabolic syndrome | 14.6 | 18.3 | 10.3 | <0.001 |
Increased waist circumference | 18.8 | 21.8 | 15.4 | <0.001 |
Elevated triglycerides | 23.4 | 32.6 | 13.1 | <0.001 |
Reduced HDL cholesterol | 31.8 | 24.6 | 40.0 | <0.001 |
Elevated blood pressure | 21.4 | 29.4 | 12.3 | <0.001 |
Elevated fasting blood glucose | 19.3 | 23.9 | 14.1 | <0.001 |
Type 2 diabetes | 2.1 | 2.6 | 1.6 | <0.001 |
Hypercholesterolemia (≥200 mg/dL) | 30.6 | 33.4 | 27.5 | <0.001 |
Hypercholesterolemia (≥240 mg/dL) | 5.9 | 6.3 | 5.4 | 0.008 |
Hypertriglyceridemia | 11.8 | 17.3 | 5.7 | <0.001 |
Atherogenic dyslipidemia | 11.5 | 13.3 | 9.6 | <0.001 |
Values are presented as mean±standard error or percentage.
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Table 2.
LDL cholesterol, mg/dL |
Pb | ||
---|---|---|---|
≥130 | <130 | ||
Men | 3,106 | 8,183 | |
BMI, kg/m2 | 24.7±0.1 | 23.5±0.1 | <0.001 |
Waist circumference, cm | 85.9±0.2 | 81.9±0.1 | <0.001 |
Total cholesterol, mg/dL | 225.2±0.6 | 172.2±0.4 | <0.001 |
Triglycerides, mg/dL | 135.9±1.5 | 131.1±1.2 | 0.008 |
HDL cholesterol, mg/dL | 46.9±0.3 | 47.5±0.2 | 0.027 |
LDL cholesterol, mg/dL | 151.0±0.5 | 98.4±0.3 | <0.001 |
Systolic blood pressure, mmHg | 119.0±0.3 | 117.0±0.2 | <0.001 |
Diastolic blood pressure, mmHg | 80.0±0.3 | 78.1±0.2 | <0.001 |
Fasting blood glucose, mg/dL | 96.0±0.4 | 93.4±0.2 | <0.001 |
Women | 3,507 | 11,129 | |
BMI, kg/m2 | 24.0±0.1 | 22.2±0.0 | <0.001 |
Waist circumference, cm | 79.3±0.3 | 74.3±0.1 | <0.001 |
Total cholesterol, mg/dL | 225.5±0.6 | 168.8±0.3 | <0.001 |
Triglycerides, mg/dL | 111.4±1.3 | 89.2±0.7 | <0.001 |
HDL cholesterol, mg/dL | 52.7±0.3 | 53.4±0.1 | 0.011 |
LDL cholesterol, mg/dL | 150.5±0.5 | 97.6±0.2 | <0.001 |
Systolic blood pressure, mmHg | 113.2±0.4 | 107.3±0.2 | <0.001 |
Diastolic blood pressure, mmHg | 74.7±0.2 | 71.0±0.1 | <0.001 |
Fasting blood glucose, mg/dL | 95.2±0.5 | 89.6±0.1 | <0.001 |
Values are presented as mean±standard error or number.
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Table 3.
Quintiles of dietary carbohydrate intake, g/day |
||||||||
---|---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | P for trend | |||
LDL cholesterol ≥130 mg/dL | ||||||||
Carbohydrate intake | 206.6±2.0 | 284.2±0.7 | 339.5±0.8 | 402.9±1.0 | 533.9±3.8 | |||
Obesity | 1.00 (Ref.) | 0.92 (0.67-1.27) | 0.98 (0.70-1.37) | 0.76 (0.54-1.07) | 0.73 (0.49-1.11) | 0.082 | ||
Metabolic syndrome | 1.00 (Ref.) | 1.40 (0.93-2.12) | 1.45 (0.93-2.27) | 1.29 (0.81-2.07) | 1.79 (1.01-3.20) | 0.130 | ||
Increased waist circumference | 1.00 (Ref.) | 0.92 (0.65-1.29) | 0.87 (0.60-1.26) | 0.64 (0.45-0.93) | 0.66 (0.42-1.03) | 0.018 | ||
Elevated triglycerides | 1.00 (Ref.) | 1.36 (0.97-1.90) | 1.16 (0.83-1.62) | 1.46 (1.04-2.05) | 1.29 (0.84-1.97) | 0.179 | ||
Reduced HDL cholesterol | 1.00 (Ref.) | 1.39 (0.97-1.97) | 1.18 (0.81-1.72) | 1.76 (1.18-2.62) | 2.33 (1.44-3.78) | <0.001 | ||
Elevated blood pressure | 1.00 (Ref.) | 0.97 (0.70-1.35) | 1.00 (0.71-1.41) | 0.84 (0.58-1.20) | 0.81 (0.52-1.27) | 0.272 | ||
Elevated fasting blood glucose | 1.00 (Ref.) | 0.83 (0.58-1.18) | 0.86 (0.59-1.25) | 0.78 (0.53-1.16) | 0.71 (0.44-1.15) | 0.181 | ||
Type 2 diabetes | 1.00 (Ref.) | 0.75 (0.29-1.96) | 1.04 (0.42-2.58) | 1.20 (0.48-3.00) | 0.61 (0.18-2.12) | 0.875 | ||
Hypercholesterolemiac | 1.00 (Ref.) | 0.65 (0.45-0.94) | 0.81 (0.56-1.18) | 0.72 (0.49-1.07) | 0.62 (0.39-0.99) | 0.112 | ||
Hypertriglyceridemia | 1.00 (Ref.) | 1.19 (0.77-1.82) | 0.95 (0.60-1.48) | 1.10 (0.71-1.73) | 1.02 (0.60-1.75) | 0.990 | ||
Atherogenic dyslipidemia | 1.00 (Ref.) | 1.49 (0.92-2.40) | 1.44 (0.88-2.36) | 1.95 (1.17-3.25) | 3.08 (1.67-5.70) | <0.001 | ||
LDL cholesterol <130 mg/dL | ||||||||
Carbohydrate intake | 202.5±1.2 | 285.1±0.6 | 341.9±0.5 | 404.6±0.6 | 540.1±2.7 | |||
Obesity | 1.00 (Ref.) | 0.94 (0.75-1.16) | 1.00 (0.81-1.23) | 0.88 (0.70-1.11) | 0.86 (0.65-1.13) | 0.264 | ||
Metabolic syndrome | 1.00 (Ref.) | 0.92 (0.69-1.23) | 1.02 (0.75-1.37) | 1.22 (0.90-1.65) | 1.19 (0.81-1.73) | 0.134 | ||
Increased waist circumference | 1.00 (Ref.) | 0.87 (0.67-1.12) | 0.88 (0.68-1.13) | 0.89 (0.68-1.18) | 0.71 (0.50-1.00) | 0.130 | ||
Elevated triglycerides | 1.00 (Ref.) | 0.95 (0.76-1.18) | 0.93 (0.74-1.17) | 0.93 (0.73-1.18) | 1.03 (0.78-1.37) | 0.990 | ||
Reduced HDL cholesterol | 1.00 (Ref.) | 1.27 (0.99-1.61) | 1.51 (1.19-1.91) | 1.77 (1.37-2.30) | 2.27 (1.65-3.13) | <0.001 | ||
Elevated blood pressure | 1.00 (Ref.) | 0.91 (0.72-1.15) | 1.15 (0.90-1.47) | 0.92 (0.72-1.19) | 0.75 (0.55-1.02) | 0.175 | ||
Elevated fasting blood glucose | 1.00 (Ref.) | 0.84 (0.66-1.08) | 0.98 (0.76-1.28) | 0.82 (0.62-1.07) | 0.73 (0.53-0.99) | 0.085 | ||
Type 2 diabetes | 1.00 (Ref.) | 0.44 (0.21-0.94) | 1.19 (0.66-2.15) | 0.51 (0.22-1.15) | 0.64 (0.30-1.39) | 0.452 | ||
Hypercholesterolemiac | 1.00 (Ref.) | 0.99 (0.75-1.29) | 0.87 (0.65-1.16) | 0.80 (0.58-1.11) | 0.84 (0.58-1.22) | 0.182 | ||
Hypertriglyceridemia | 1.00 (Ref.) | 1.33 (1.02-1.72) | 1.26 (0.97-1.65) | 1.23 (0.92-1.66) | 1.29 (0.91-1.82) | 0.318 | ||
Atherogenic dyslipidemia | 1.00 (Ref.) | 1.29 (0.97-1.73) | 1.24 (0.92-1.66) | 1.56 (1.13-2.15) | 2.25 (1.50-3.37) | <0.001 |
Values are presented as mean±standard error or OR (95% CI).
Abbreviations: CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OR, odds ratio; Ref., reference.
a All analyses accounted for the complex sampling design effect and appropriate sampling weights of the national survey using the PROC SURVEY in the SAS program (SAS Institute, Cary, NC, USA).
Table 4.
Quintiles of dietary carbohdyrate intake, g/day |
||||||||
---|---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | P for trend | |||
LDL cholesterol ≥130 mg/dL | ||||||||
Carbohydrate intake | 153.7±1.4 | 219.9±0.7 | 270.3±0.6 | 324.1±0.9 | 448.0±4.0 | |||
Obesity | 1.00 (Ref.) | 0.82 (0.58-1.15) | 0.91 (0.63-1.33) | 0.98 (0.66-1.46) | 0.83 (0.47-1.46) | 0.879 | ||
Metabolic syndrome | 1.00 (Ref.) | 1.20 (0.74-1.94) | 1.20 (0.73-1.98) | 1.33 (0.75-2.37) | 1.04 (0.49-2.21) | 0.596 | ||
Increased waist circumference | 1.00 (Ref.) | 0.88 (0.60-1.30) | 1.17 (0.79-1.74) | 1.12 (0.72-1.74) | 0.88 (0.48-1.60) | 0.751 | ||
Elevated triglycerides | 1.00 (Ref.) | 1.11 (0.74-1.68) | 1.16 (0.76-1.76) | 1.33 (0.84-2.11) | 0.96 (0.51-1.82) | 0.548 | ||
Reduced HDL cholesterol | 1.00 (Ref.) | 1.39 (0.99-1.94) | 1.36 (0.95-1.95) | 1.59 (1.06-2.37) | 1.62 (0.94-2.80) | 0.060 | ||
Elevated blood pressure | 1.00 (Ref.) | 1.32 (0.87-2.01) | 0.69 (0.43-1.11) | 1.15 (0.70-1.90) | 0.69 (0.35-1.38) | 0.436 | ||
Elevated fasting blood glucose | 1.00 (Ref.) | 0.84 (0.56-1.27) | 0.95 (0.61-1.48) | 1.04 (0.62-1.74) | 1.09 (0.55-2.18) | 0.687 | ||
Type 2 diabetes | 1.00 (Ref.) | 0.44 (0.16-1.22) | 0.30 (0.11-0.83) | 0.47 (0.16-1.44) | 0.17 (0.03-0.93) | 0.096 | ||
Hypercholesterolemiac | 1.00 (Ref.) | 1.18 (0.82-1.69) | 1.20 (0.82-1.77) | 1.09 (0.72-1.66) | 0.99 (0.56-1.77) | 0.977 | ||
Hypertriglyceridemia | 1.00 (Ref.) | 1.19 (0.68-2.09) | 0.96 (0.53-1.75) | 1.38 (0.66-2.88) | 0.97 (0.30-3.15) | 0.738 | ||
Atherogenic dyslipidemia | 1.00 (Ref.) | 1.14 (0.72-1.83) | 1.19 (0.73-1.94) | 1.40 (0.80-2.42) | 1.29 (0.62-2.67) | 0.312 | ||
LDL cholesterol <130 mg/dL | ||||||||
Carbohydrate intake | 153.4±0.8 | 219.9±0.4 | 268.9±0.4 | 324.6±0.4 | 445.3±2.4 | |||
Obesity | 1.00 (Ref.) | 0.81 (0.65-1.02) | 0.82 (0.64-1.06) | 0.84 (0.64-1.12) | 0.81 (0.57-1.17) | 0.344 | ||
Metabolic syndrome | 1.00 (Ref.) | 1.27 (0.89-1.82) | 0.90 (0.59-1.37) | 1.02 (0.65-1.60) | 0.86 (0.48-1.54) | 0.476 | ||
Increased waist circumference | 1.00 (Ref.) | 0.84 (0.64-1.10) | 0.83 (0.62-1.11) | 0.95 (0.69-1.29) | 0.82 (0.55-1.22) | 0.618 | ||
Elevated triglycerides | 1.00 (Ref.) | 1.12 (0.85-1.47) | 1.05 (0.77-1.43) | 1.00 (0.71-1.42) | 1.14 (0.74-1.75) | 0.878 | ||
Reduced HDL cholesterol | 1.00 (Ref.) | 1.08 (0.89-1.30) | 1.18 (0.97-1.44) | 1.26 (1.01-1.57) | 1.33 (0.99-1.78) | 0.025 | ||
Elevated blood pressure | 1.00 (Ref.) | 0.94 (0.71-1.23) | 0.88 (0.65-1.20) | 0.80 (0.56-1.14) | 0.83 (0.52-1.32) | 0.282 | ||
Elevated fasting blood glucose | 1.00 (Ref.) | 1.06 (0.80-1.41) | 1.13 (0.83-1.55) | 0.96 (0.69-1.33) | 0.74 (0.48-1.12) | 0.294 | ||
Type 2 diabetes | 1.00 (Ref.) | 1.95 (0.63-6.10) | 2.26 (0.66-7.72) | 1.15 (0.32-4.08) | 2.06 (0.29-14.58) | 0.723 | ||
Hypercholesterolemiac | 1.00 (Ref.) | 0.84 (0.63-1.12) | 0.89 (0.66-1.20) | 0.51 (0.36-0.72) | 0.62 (0.41-0.94) | 0.002 | ||
Hypertriglyceridemia | 1.00 (Ref.) | 0.89 (0.62-1.29) | 0.94 (0.61-1.43) | 0.67 (0.43-1.04) | 0.73 (0.41-1.29) | 0.146 | ||
Atherogenic dyslipidemia | 1.00 (Ref.) | 1.30 (0.95-1.78) | 1.25 (0.87-1.78) | 1.20 (0.80-1.80) | 1.46 (0.88-2.41) | 0.328 |
Values are presented as mean±standard error or OR (95% CI).
Abbreviations: CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OR, odds ratio; Ref., reference.
a All analyses accounted for the complex sampling design effect and appropriate sampling weights of the national survey using the PROC SURVEY in the SAS program (SAS Institute, Cary, NC, USA).